278 related articles for article (PubMed ID: 21944866)
1. Common polymorphisms in the GH/IGF-1 axis contribute to growth in extremely tall subjects.
Hendriks AE; Brown MR; Boot AM; Oostra BA; de Jong FH; Drop SL; Parks JS
Growth Horm IGF Res; 2011 Dec; 21(6):318-24. PubMed ID: 21944866
[TBL] [Abstract][Full Text] [Related]
2. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL
Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
[TBL] [Abstract][Full Text] [Related]
4. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
Safarinejad MR; Shafiei N; Safarinejad SH
Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
[TBL] [Abstract][Full Text] [Related]
5. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
Mericq V; Román R; Iñiguez G; Angel B; Salazar T; Avila A; Perez-Bravo F; Cassorla F
Horm Res; 2007; 68(3):132-8. PubMed ID: 17347571
[TBL] [Abstract][Full Text] [Related]
6. No effect of the IGF-1 gene rs35767 and rs17032362 polymorphisms in the etiology of idiopathic short stature.
Tekcan D; Baş F; Atalar F; Aydin BK; Akan G; Tarhan T; Bundak R; Darendeliler F
Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):395-400. PubMed ID: 22689104
[TBL] [Abstract][Full Text] [Related]
7. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height.
Rietveld I; Janssen JA; van Rossum EF; Houwing-Duistermaat JJ; Rivadeneira F; Hofman A; Pols HA; van Duijn CM; Lamberts SW
Clin Endocrinol (Oxf); 2004 Aug; 61(2):195-203. PubMed ID: 15272914
[TBL] [Abstract][Full Text] [Related]
8. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
[TBL] [Abstract][Full Text] [Related]
9. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
[TBL] [Abstract][Full Text] [Related]
10. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
11. Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.
Wan L; Chen WC; Tsai Y; Kao YT; Hsieh YY; Lee CC; Tsai CH; Chen CP; Tsai FJ
Pediatr Res; 2007 Dec; 62(6):735-40. PubMed ID: 17957148
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
[TBL] [Abstract][Full Text] [Related]
13. Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.
Deal C; Ma J; Wilkin F; Paquette J; Rozen F; Ge B; Hudson T; Stampfer M; Pollak M
J Clin Endocrinol Metab; 2001 Mar; 86(3):1274-80. PubMed ID: 11238520
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
15. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
Safarinejad MR; Shafiei N; Safarinejad S
Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
[TBL] [Abstract][Full Text] [Related]
16. Characterizing short stature by insulin-like growth factor axis status and genetic associations: results from the prospective, cross-sectional, epidemiogenetic EPIGROW study.
Clayton P; Bonnemaire M; Dutailly P; Maisonobe P; Naudin L; Pham E; Zhang Z; Grupe A; Thiagalingam A; Denèfle P;
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1122-30. PubMed ID: 23596138
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal epiphyseal chondrocytes.
Fernández-Cancio M; Audi L; Carrascosa A; Toran N; Andaluz P; Esteban C; Granada ML
Growth Horm IGF Res; 2009 Jun; 19(3):232-7. PubMed ID: 19056306
[TBL] [Abstract][Full Text] [Related]
19. The endocrine consequences for very low birth weight premature infants.
Cutfield WS; Regan FA; Jackson WE; Jefferies CA; Robinson EM; Harris M; Hofman PL
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S130-5. PubMed ID: 15135795
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
